Szafran Brittany N, Borazjani Abdolsamad, Scheaffer Hannah L, Crow J Allen, McBride Ann Marie, Adekanye Oluwabori, Wonnacott Caitlin B, Lehner Richard, Kaplan Barbara L F, Ross Matthew K
Department of Comparative Biomedical Sciences, Center for Environmental Health Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi39762, United States.
Department of Biochemistry, Molecular Biology, Entomology, and Plant Pathology, College of Agriculture and Life Sciences, Mississippi State University, Mississippi State, Mississippi39762, United States.
ACS Pharmacol Transl Sci. 2022 Sep 12;5(10):919-931. doi: 10.1021/acsptsci.2c00098. eCollection 2022 Oct 14.
Carboxylesterases are members of the serine hydrolase superfamily and metabolize drugs, pesticides, and lipids. Previous research showed that inhibition of carboxylesterase 1 (CES1) in human macrophages altered the immunomodulatory effects of lipid mediators called prostaglandin glyceryl esters, which are produced by cyclooxygenase-catalyzed oxygenation of the endocannabinoid 2-arachidonoylglycerol (2-AG). Ces1d - the mouse ortholog of human CES1 - is the most abundant Ces isoform in murine lung tissues and alveolar macrophages and a major target of organophosphate poisons. Monoacylglycerol lipase (Magl) is also expressed in murine lung and is the main enzyme responsible for 2-AG catabolism. Several metabolic benefits are observed in Ces1d mice fed a high-fat diet; thus, we wondered whether pharmacological and genetic inactivation of Ces1d in vivo might also ameliorate the acute inflammatory response to lipopolysaccharide (LPS). C57BL/6 mice were treated with WWL229 (Ces1d inhibitor) or JZL184 (Magl inhibitor), followed 30 min later by either LPS or saline. Wild-type (WT) and Ces1d mice were also administered LPS to determine the effect of Ces1d knockout. Mice were sacrificed at 6 and 24 h, and cytokines were assessed in serum, lung, liver, and adipose tissues. Lipid mediators were quantified in lung tissues, while activity-based protein profiling and enzyme assays determined the extent of lung serine hydrolase inactivation by the inhibitors. WWL229 was shown to augment LPS-induced lung inflammation in a female-specific manner, as measured by enhanced neutrophil infiltration and Il1b mRNA. The marked Ces inhibition in female lung by 4 h after drug treatment might explain this sex difference, although the degree of Ces inhibition in female and male lungs was similar at 6 h. In addition, induction of lung Il6 mRNA and prostaglandin E by LPS was more pronounced in Ces1d mice than in WT mice. Thus, WWL229 inhibited lung Ces1d activity and augmented the female lung innate immune response, an effect observed in part in Ces1d mice and Ces1d/CES1-deficient murine and human macrophages. In contrast, JZL184 attenuated LPS-induced Il1b and Il6 mRNA levels in female lung, suggesting that Ces1d and Magl have opposing effects. Mapping the immunomodulatory molecules/pathways that are regulated by Ces1d in the context of lung inflammation will require further research.
羧酸酯酶是丝氨酸水解酶超家族的成员,可代谢药物、农药和脂质。先前的研究表明,抑制人类巨噬细胞中的羧酸酯酶1(CES1)会改变一类名为前列腺素甘油酯的脂质介质的免疫调节作用,这类介质由环氧合酶催化内源性大麻素2-花生四烯酸甘油酯(2-AG)的氧化反应产生。Ces1d是人类CES1在小鼠中的同源物,是小鼠肺组织和肺泡巨噬细胞中最丰富的Ces同工型,也是有机磷酸酯类毒物的主要作用靶点。单酰甘油脂肪酶(Magl)也在小鼠肺中表达,是负责2-AG分解代谢的主要酶。在喂食高脂饮食的Ces1d小鼠中观察到了几种代谢益处;因此,我们想知道体内对Ces1d进行药理学和基因失活是否也能改善对脂多糖(LPS)的急性炎症反应。用WWL229(Ces1d抑制剂)或JZL184(Magl抑制剂)处理C57BL/6小鼠,30分钟后再注射LPS或生理盐水。也给野生型(WT)和Ces1d基因敲除小鼠注射LPS以确定Ces1d基因敲除的影响。在6小时和24小时处死小鼠,并评估血清、肺、肝和脂肪组织中的细胞因子。对肺组织中的脂质介质进行定量,同时基于活性的蛋白质谱分析和酶分析确定抑制剂对肺丝氨酸水解酶的失活程度。结果显示,WWL229以雌性特异性方式增强LPS诱导的肺部炎症,这通过中性粒细胞浸润增加和Il1b mRNA表达来衡量。药物治疗4小时后雌性肺中明显的Ces抑制作用可能解释了这种性别差异,尽管在6小时时雌性和雄性肺中的Ces抑制程度相似。此外,LPS诱导的肺Il6 mRNA和前列腺素E在Ces1d基因敲除小鼠中比在WT小鼠中更明显。因此,WWL229抑制肺Ces1d活性并增强雌性肺的固有免疫反应,这种作用在Ces1d基因敲除小鼠以及Ces1d/CES1缺陷的小鼠和人类巨噬细胞中部分观察到。相比之下,JZL184减弱了LPS诱导的雌性肺中Il1b和Il6 mRNA水平,这表明Ces1d和Magl具有相反的作用。在肺部炎症背景下确定由Ces1d调节的免疫调节分子/途径还需要进一步研究。